First human test: does new drug affect the Heart's rhythm?
NCT ID NCT07272629
Summary
This is an early safety study to see if a single dose of an investigational drug called balinatunfib affects the electrical timing of the heart in healthy people. It will involve 44 healthy adult volunteers who will receive the drug, a placebo, and a comparison drug in a specific order. The main goal is to carefully measure the drug's effect on the heart's rhythm and see how the body processes it.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
FORTREA CLINICAL RESEARCH UNIT INC- Site Number : 8400001
RECRUITINGMadison, Wisconsin, 53704, United States
-
FORTREA CLINICAL RESEARCH UNIT INC- Site Number : 8400002
RECRUITINGDallas, Texas, 75247, United States
Conditions
Explore the condition pages connected to this study.